Literature DB >> 2356813

Illicit drug use and the risk of new-onset seizures.

S K Ng1, J C Brust, W A Hauser, M Susser.   

Abstract

The authors studied the use of heroin, marijuana, and cocaine before the onset of a first seizure in 308 patients with seizures and 294 controls at Harlem Hospital Center, New York City, between 1981 and 1984. Heroin use, both past and present, appeared to be a risk factor for all first seizures (adjusted odds ratio = 2.80, 95% confidence interval (CI) 1.53-5.74). For unprovoked seizures, the adjusted odds ratio was 2.58 (95% CI 1.36-4.90) for ever heroin use and 4.70 (95% CI 0.86-25.78) for heroin use within 24 hours of hospitalization. For provoked seizures, respective adjusted odds ratios were 3.65 (95% CI 1.54-8.65) and 27.74 (95% CI 3.57-215.52). Marijuana use appeared to be a protective factor against first seizures in men. For men with unprovoked seizures, the adjusted odds ratio was 0.42 (95% CI 0.22-0.82) for ever marijuana use and 0.36 (95% CI 0.18-0.74) for marijuana use within 90 days of hospitalization. For men with provoked seizures, respective adjusted odds ratios were 1.03 (95% CI 0.36-2.89) and 0.18 (95% CI 0.04-0.84). Cocaine use, while common among study subjects, was not shown to be a significant risk factor either for all first seizures or for subgroups of seizures, regardless of the time of last use. The authors conclude that heroin use is a risk factor and marijuana use a protective factor for new-onset seizures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2356813     DOI: 10.1093/oxfordjournals.aje.a115642

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  16 in total

1.  Convulsions associated with the use of a synthetic cannabinoid product.

Authors:  Aaron B Schneir; Todd Baumbacher
Journal:  J Med Toxicol       Date:  2012-03

2.  Medical Marijuana for Epilepsy?

Authors:  Murali K Kolikonda; Kavitha Srinivasan; Manasa Enja; Vishwanath Sagi; Steven Lippmann
Journal:  Innov Clin Neurosci       Date:  2016-04-01

3.  Hallucinogens causing seizures? A case report of the synthetic amphetamine 2,5-dimethoxy-4-chloroamphetamine.

Authors:  Mark J Burish; Katie L Thoren; Maura Madou; Shahed Toossi; Maulik Shah
Journal:  Neurohospitalist       Date:  2015-01

Review 4.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 5.  Plant-Derived and Endogenous Cannabinoids in Epilepsy.

Authors:  Alberto Verrotti; Miriam Castagnino; Mauro Maccarrone; Filomena Fezza
Journal:  Clin Drug Investig       Date:  2016-05       Impact factor: 2.859

Review 6.  [Therapeutic use of cannabinoids in neurology].

Authors:  P Schwenkreis; M Tegenthoff
Journal:  Schmerz       Date:  2003-10       Impact factor: 1.107

7.  Influence of nebivolol on anticonvulsant effect of lamotrigine.

Authors:  Radha Goel; Amit Goel; Anshu Manocha; K K Pillai; Rashmi S Srivastava
Journal:  Indian J Pharmacol       Date:  2009-02       Impact factor: 1.200

Review 8.  Seizures, illicit drugs, and ethanol.

Authors:  John C M Brust
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

Review 9.  Drug-induced seizures in the elderly. Causative agents and optimal management.

Authors:  K L Franson; D P Hay; V Neppe; W Y Dahdal; W U Mirza; G T Grossberg; D M Chatel; P A Szwabo; S Kotegal
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

Review 10.  Cannabinoids for epilepsy.

Authors:  David Gloss; Barbara Vickrey
Journal:  Cochrane Database Syst Rev       Date:  2014-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.